Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
DCV
DRUG
2 trials
Sponsors
ViiV Healthcare
, Bristol-Myers Squibb
Conditions
Hepatitis C
Infection, Human Immunodeficiency Virus
Phase 1
Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects
Completed
NCT02082808
ViiV Healthcare
Infection, Human Immunodeficiency Virus
Start: 2014-03-31
End: 2014-05-31
Updated: 2014-06-09
Phase 3
A Study of Daclatasvir and Sofosbuvir With Ribavirin in Subjects With Cirrhosis and Genotype 3 Hepatitis C Infection
Completed
NCT02673489
Bristol-Myers Squibb
Hepatitis C
Start: 2016-03-15
End: 2017-05-26
Updated: 2018-05-08
Related Papers
Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C).
2019-01-01
7 citations
No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects
BMC Infectious Diseases
2016-07-22
6 citations